IMARC Group's report titled "Japan Coronary Stents Market Report by Type (Drug-Eluting Stents, Bare-Metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery ( Balloon-Expandable Stents, Self-Expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032". Japan coronary stents market size is projected to exhibit a growth rate (CAGR) of 4.42% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/japan-coronary-stents-market/requestsample
Factors Affecting the Growth of the Japan Coronary Stents Industry:
- Prevalence of Cardiovascular Diseases:
The rising prevalence of cardiovascular diseases, including coronary artery diseases, represents one of the primary factors driving the demand for coronary stents in Japan. In addition, the expanding working population, sedentary lifestyles, and unhealthy dietary habits are leading to a higher incidence of heart-related disorders, which is catalyzing the demand for advanced medical interventions like coronary stents to address and manage coronary artery blockages. Moreover, the increasing global geriatric population, which is more susceptible to cardiovascular diseases, is facilitating the market growth.
- Importance of Early Disease Diagnosis:
The growing awareness among the masses about cardiovascular health and the importance of early disease diagnosis are facilitating the market growth. Along with this, continuous advancements in diagnostic technologies are contributing to an earlier and more accurate diagnosis of coronary artery diseases. In line with this, the increasing consciousness among people about the risk factors and symptoms associated with heart conditions is encouraging them to seek medical attention sooner. This proactive approach to healthcare is driving the demand for timely and effective interventions, including the use of coronary stents, to manage and alleviate the impact of coronary artery blockages.
- Government Initiatives Supporting Interventional Cardiology: Governing authorities of Japan are undertaking several initiatives and improving healthcare policies, which is contributing to the growth of the market. Policies that promote early diagnosis, preventive care, and advancements in interventional cardiology are creating a favorable environment for the coronary stents market. In line with this, the rising collaborations between the government and healthcare providers are facilitating the accessibility and affordability of coronary stents. Moreover, the integration of coronary stents into health insurance coverage plans, supported by government policies, is enhancing the affordability of these interventions for patients.
Leading Companies Operating in the Japan Coronary Stents Industry:
- Abbott Japan Co. Ltd. (Abbott Laboratories)
- Medtronic Japan Co. Ltd. (Medtronic plc)
- Terumo Corporation
Japan Coronary Stents Market Report Segmentation:
By Type:
- Drug-Eluting Stents
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
Based on the type, the market has been classified into drug-eluting stents, bare-metal coronary stents, and bioabsorbable stents.
By Biomaterial:
- Metallic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
On the basis of the biomaterial, the market has been segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial.
By Mode of Delivery:
- Balloon-Expandable Stents
- Self-Expanding Stents
Based on the mode of delivery, the market has been divided into balloon-expandable stents and self-expanding stents.
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
On the basis of the end user, the market has been bifurcated into hospitals, ambulatory surgical centers, and others.
Regional Insights:
- Kanto Region
- Kansai/Kinki Region
- Central/ Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
Region wise, the market has been segregated into Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
Japan Coronary Stents Market Trends:
The rising preferences of people for interventions that involve smaller incisions, shorter recovery times, and reduced post-operative complications are creating a positive outlook for the market. The advancement of techniques such as percutaneous coronary intervention (PCI) is making it possible to treat coronary artery diseases effectively with less invasive procedures, driving the demand for coronary stents as a key component of these interventions.
The growing emphasis on reducing long-term complications associated with traditional stents is influencing the market positively. In addition, the widespread adoption of bioresorbabe stents to provide necessary support during the initial healing phase is driving the market.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
